SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Cash Cat

Cash Cat is generating significant community buzz following its listing on the Robinhood platform, with traders actively debating its potential as a leading meme coin on the new chain. While some participants are aggressively accumulating the token in anticipation of further momentum, others are monitoring the broader rotation of speculative capital and ongoing price volatility.

Berkshire Hathaway, Inc. is a holding company, which engages in the provision of property and casualty insurance and reinsurance, utilities and energy, freight rail transportation, finance, manufacturing, and retailing services. It operates through the following segments: Insurance, Burlington Northern Santa Fe, LLC (BNSF), Berkshire Hathaway Energy (BHE), Pilot Travel Centers (PTC), Manufacturing, McLane, and Service and Retailing. The Insurance segment includes the underwriting of GEICO, Berkshire Hathaway Primary Group, and Berkshire Hathaway Reinsurance Group. The BNSF segment involves the operation of railroad systems. The BHE segment focuses on regulated electric and gas utility, power generation and distribution, and real estate brokerage activities. The PTC segment consists of managing travel centers and marketing of wholesale fuel. The Manufacturing segment refers to industrial, consumer and building products, home building, and related financial services. The McLane segment covers the wholesale distribution of groceries and non-food items. The Service and Retailing segment relates to the provision of shared aircraft ownership programs, aviation pilot training, electronic components distribution, retailing businesses, automobile dealerships and trailer, and furniture leasing services. The company was founded by Oliver Chace in 1839 and is headquartered in Omaha, NE.

Berkshire Hathaway Inc. - Ordinary Shares - Class B

Berkshire Hathaway is trending as investors digest a strong earnings report showing a significant rise in operating profits and the company's shift toward net equity buying for the first time in years. The community is actively debating the effectiveness of the leadership's capital deployment strategy, balancing the firm's massive cash position against its recent investments in tech-focused equities and share buybacks.

Venture Global, Inc. engages in the provision of United States liquefied natural gas sourced from resource rich North American natural gas basins. It operates through the following segments: Calcasieu Project, Plaquemines Project, CP2 Project, and Sales and shipping. The company was founded by Michael Sabel and Robert Pender in 2023 and is headquartered in Arlington, VA.

Venture Global Inc. - Ordinary Shares - Class A

Venture Global Inc

Venture Global is trending as investors weigh significant geopolitical disruptions in the Strait of Hormuz against ongoing market volatility driven by algorithmic trading and energy sector rotations. The community is actively discussing the company's long-term infrastructure expansion and potential for massive cash flow generation, while debating whether current price action is a temporary manipulation or reflective of broader commodity market instability.

United Parcel Service, Inc. is a package delivery company, which engages in the provision of global supply chain management solutions. It operates through the following segments: U.S. Domestic Package and International Package. The U.S. Domestic Package segment includes time-definite delivery of letters, documents, and packages. The International Package segment focuses on delivery and shipments in Europe, Asia, the Indian sub-continent, the Middle East, Africa, Canada, and Latin America. The company was founded by James E. Casey and Claude Ryan on August 28, 1907 and is headquartered in Atlanta, GA.

United Parcel Service, Inc. - Ordinary Shares - Class B

United Parcel Service, Inc.

United Parcel Service (UPS) is attracting significant investor attention as markets weigh the long-term impact of its strategic network restructuring and the competitive pressure of Amazon's expanding logistics services. Community discussion is polarized, with some bulls highlighting the company's robust dividend yield and potential for a turnaround as a deep-value play, while bears express ongoing concerns regarding high labor costs, intense competition, and management's ability to maintain margins.

Xeris Biopharma Holdings, Inc. is a biopharmaceutical company, which engages in developing and commercializing products across a range of therapies. Its products include Gvoke, Keveyis, and Recorlev. Gvoke is a ready-to-use liquid glucagon for the treatment of severe hypoglycemia. Keveyis is the therapy approved in the United States to treat hyperkalemic, hypokalemic, and related variants of primary periodic paralysis (PPP). Recorlev is a cortisol synthesis inhibitor approved for the treatment of endogenous hypercortisolemia in adult patients with Cushing’s syndrome. The company was founded by Steven Prestrelski in 2005 and is headquartered in Chicago, IL.

Xeris Biopharma Holdings Inc

Xeris Biopharma is trending as investors await the upcoming investor webinar and phase 3 trial details for XP-8121, viewed by many as a potential blockbuster in the endocrinology space. Community sentiment remains focused on the company's strong financial indicators, such as debt reduction and revenue growth, leading to active speculation about both long-term holding potential and possible M&A activity.

Berkshire Hathaway Inc. - Ordinary Shares - Class A

Berkshire Hathaway is trending following reports that the conglomerate has initiated a significant new stake in Alphabet, fueling speculation about the company's long-term strategy in AI and its broader capital deployment efforts. The community is actively discussing the investment's potential as a signal of confidence in the tech sector, while debating the firm's evolving management approach as it prepares for its leadership transition.

Revolution Medicines, Inc. is a clinical-stage precision oncology company, which engages in developing novel targeted therapies. It engages in the discovery and development of cancer treatment by pioneering novel combination and monotherapy treatment regimens to maximize the depth and durability of clinical benefit and circumvent adaptive resistance mechanisms for patients which are dependent on the RAS and mTOR pathway. The company was founded by Mark A. Goldsmith, Kevan Shokat, Martin D. Burke, David L. Pompliano and Michael Fischbach in October 2014 and is headquartered in Redwood City, CA.

Revolution Medicines Inc

Revolution Medicines is experiencing significant momentum as investors digest the recent clinical success of its lead RAS(ON) inhibitor in metastatic pancreatic cancer, which demonstrated an unprecedented improvement in overall survival. The community is heavily focused on the stock's potential as a major acquisition target, with active discussions comparing its robust pipeline and valuation to other oncology innovators and speculating on the timing of a potential buyout.

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.

CVS Health Corp

CVS Health is trending as the market digests the company's Q2 earnings beat, which included raised full-year guidance and analyst price target upgrades from firms like UBS and DA Davidson. While investors are debating the long-term outlook for Caremark and overall margin recovery, community discussion is dominated by arguments that the sell-off following earnings was an overreaction driven by algorithmic trading.

Northrop Grumman Corp. engages in the provision of advanced aircraft systems. It operates through the following segments: Aeronautics Systems, Defense Systems, Mission Systems, and Space Systems. The Aeronautics Systems segment is involved in the design, development, production, integration, sustainment, and modernization of advanced aircraft systems for the U.S. Air Force, the U.S. Navy, other U.S. government agencies, and international customers. The Defense Systems segment includes integrated battle management systems, weapons systems and aircraft, and mission systems sustainment and modernization. The Mission Systems segment offers advanced mission solutions and multifunction systems, primarily for the U.S. defense and intelligence community, and international customers. The Space Systems segment delivers end-to-end mission solutions through the design, development, integration, production and operation of space, missile defense, launch and strategic missile systems for national security, civil government, commercial, and international customers. The company was founded by John K. Northrop, Thomas V. Jones, and Kent Kresa in 1939 and is headquartered in Falls Church, VA.

Northrop Grumman Corp.

Northrop Grumman is trending as investors monitor ongoing defense sector rotation driven by sustained geopolitical tensions and the anticipation of higher procurement spending. The community is actively discussing the company's robust contract backlog and evaluating its long-term growth potential against broader aerospace market volatility.

Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. The firm is involved in the clinical trials at cancer centers with indications that include skin cancer, oral cavity cancer, breast cancer, and pancreatic cancer. The company was founded by Uzi Sofer, Yona Keisari, and Itzhak Kelson in November 2015 and is headquartered in Jerusalem, Israel.

Alpha Tau Medical Ltd

ALPHA TAU MEDICAL LTD

The community is actively tracking Alpha Tau Medical as it approaches a major podium presentation at the AHNS conference, where the company is expected to release trial data combining its Alpha DaRT platform with the immunotherapy drug Keytruda. Investors are highly optimistic about the synergy between these treatments, viewing the upcoming event as a significant catalyst that could further validate the company's oncology pipeline and drive institutional interest.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Karman Holdings is generating significant investor buzz following a robust quarterly report that highlighted record revenue, a substantial backlog growth, and raised full-year guidance. The community is actively discussing the stock's role as a mission-critical supplier in the defense and space sectors, with many focusing on the disconnect between its strong operational fundamentals and recent market volatility.

Karman Holdings Inc. (KRMN) Q2 Earnings and Revenues Top Estimates

Karman Holdings Inc. (KRMN) delivered earnings and revenue surprises of +7.69% and +1.20%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Compared to Estimates, Karman Holdings Inc. (KRMN) Q2 Earnings: A Look at Key Metrics

Although the revenue and EPS for Karman Holdings Inc. (KRMN) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Karman Space & Defense Reports Second Quarter Fiscal Year 2026 Financial Results

Karman Space & Defense (Karman, Karman Holdings, Inc. or the Company) (NYSE: KRMN), a leader in the rapid design, development, and production of critical, next-generation systems that align with the core mission priorities of the U.S. Department of War and its allies, and meet the accelerating...

The Infrastructure Under America's Busiest Spaceport Was Built for Another Era. New Legislation Would Let Private Companies Help Modernize It.

The Infrastructure Under America's Busiest Spaceport Was Built for Another Era. New Legislation Would Let Private Companies Help Modernize It. The Infrastructure Under America's Busiest Spaceport Was Built for Another Era. New Legislation Would Let Private Companies Help Modernize It. PR Newswire...

Leonardo DRS, Inc. (DRS) Surpasses Q2 Earnings and Revenue Estimates

Leonardo DRS, Inc. (DRS) delivered earnings and revenue surprises of +29.63% and +1.51%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Karman Space & Defense Schedules Second Quarter Fiscal Year 2026 Earnings Release, Conference Call and Webcast

Karman Space & Defense (NYSE: KRMN) ("Karman" or the Company), a leader in the rapid design, development, and production of critical, next-generation systems that align with the core mission priorities of the U.S. Department of War and its allies, and meet the accelerating demand for access to...

Karman Space & Defense Awarded $21.3 Million Contract by Northrop Grumman for U.S. Navy MK 54 Torpedo Fleet Exercise Section

Karman Space & Defense (Karman, Karman Holdings Inc. or the Company) (NYSE: KRMN), a leader in the rapid design, development and production of critical, next-generation system solutions that align with the U.S. Department of Defenses core mission priorities and the nations accelerating demand for...

Karman Space & Defense Expands into International Market with Agreement to Acquire Glasgow-Headquartered Walker Precision Engineering, a Leading Supplier to the European Missile Industry, for $94 Million

Farnborough Airshow -- Karman Space & Defense (Karman, Karman Holdings, Inc. or the Company) (NYSE: KRMN), a leader in the rapid design, development, and production of critical, next-generation systems that align with the core mission priorities of the U.S. Department of War and its allies, and...

Why Karman Holdings Stock Zoomed More Than 6% Higher Today

Key PointsStarting Friday, it will be a component stock on the S&P SmallCap 600 index...

BrightSpring Health Services Set to Join S&P MidCap 400 and Karman Holdings to Join S&P SmallCap 600

BrightSpring Health Services Set to Join S&P MidCap 400 and Karman Holdings to Join S&P SmallCap 600 BrightSpring Health Services Set to Join S&P MidCap 400 and Karman Holdings to Join S&P SmallCap 600 PR Newswire NEW YORK, July 14, 2026 NEW YORK, July 14, 2026 /PRNewswire/ -- S&PSmallCap 600...

$KRMN Q2 &#39;26 Earnings Results &amp; Recap

• Reported GAAP EPS of $0.11 up 120.00% YoY
• Reported revenue of $182.06M up 58.18% YoY
• For the full fiscal year 2026, Karman Holdings raises its expectations for total revenue to between $730 million and $745 million, and for non-GAAP Adjusted EBITDA to between $215 million and $222.5 million.

Stocktwits

Karman Holdings Ord Shs

 Q2 '26 Earnings Results & Recap

• Reported GAAP EPS of $0.11 up 120.00% YoY
• Reported revenue of $182.06M up 58.18% YoY
• For the full fiscal year 2026, Karman Holdings raises its expectations for total revenue to between $730 million and $745 million, and for non-GAAP Adjusted EBITDA to between $215 million and $222.5 million.

This account has been verified as an official STOCKTWITS representative.

Verified Account

Stocktwits Earnings

Karman Holdings, Inc. engages in the design, testing, manufacturing, and sale of dependable missile systems. It offers Payload Protection & Deployment Systems, Aerodynamic Interstage Systems, and Propulsion Systems. The company was founded on August 20, 2020 and is headquartered in Huntington Beach, CA.

Karman Holdings Inc.

Karman Space & Defense Stock Is Rising – Know Why

Equity

Extremely Bullish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Earnings

Fundamentals

Info

KRMNKarman Holdings Ord Shs

Fundamentals

Connect Stocktwits to ChatGPT

Latest KRMN News